MyoKardia Inc - Company Profile
Powered by
All the data and insights you need on MyoKardia Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date MyoKardia Inc Strategy Report
- Understand MyoKardia Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on MyoKardia Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
EP4054588A1 | Application | VERFAHREN ZUR BEHANDLUNG MIT MYOSIN-MODULATOR | A61K31/513; A61P9/04 | September 14, 2022 |
CN114945372A | Application | 用肌球蛋白调节剂的治疗方法 | A61K31/513; A61P9/04 | August 26, 2022 |
US20220265629A1 | Application | TREATMENT OF SYSTOLIC DYSFUNCTION AND HEART FAILURE WITH REDUCED EJECTION FRACTION WITH THE COMPOUND (R)-4-(1-((3-(DIFLUOROMETHYL)-1-METHYL-1H-PYRAZOL-4-YL)SULFONYL)-1-FLUOROETHYL)-N-(ISOXAZOL-3-YL)PIPERIDINE-1-CARBOXAMIDE | A61K31/454; A61K45/06; A61K9/14; A61K9/20; A61K9/48 | August 25, 2022 |
KR1020220113387A | Application | 미오신 조절제를 사용한 치료 방법 | A61K31/513; A61P9/04 | August 12, 2022 |
JP2022535195A | Application | 収縮不全の処置 | A61K31/454; A61K45/06; A61K9/0053; A61K9/0095; A61K9/20; A61K9/48; A61P11/00; A61P3/00; A61P3/10; A61P31/12; A61P7/10; A61P9/00; A61P9/02; A61P9/04; A61P9/10; A61P9/12 | August 05, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer